Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
23.27
+0.16 (0.69%)
At close: May 6, 2026, 4:00 PM EDT
23.02
-0.25 (-1.07%)
After-hours: May 6, 2026, 7:38 PM EDT
Immunome Market Cap
Immunome has a market cap or net worth of $2.64 billion as of May 6, 2026. Its market cap has increased by 270.06% in one year.
Market Cap
2.64B
Enterprise Value
1.99B
1-Year Change
270.06%
Ranking
Category
Stock Price
$23.27
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $2.64B, an increase of 2,265.83%. That is a compound annual growth rate of 76.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 2.64B | 11.20% |
| Dec 31, 2025 | 2.37B | 257.53% |
| Dec 31, 2024 | 662.87M | 44.98% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tarsus Pharmaceuticals | 2.75B |
| Soleno Therapeutics | 2.74B |
| Kodiak Sciences | 2.62B |
| Disc Medicine | 2.58B |
| Celldex Therapeutics | 2.57B |
| Vera Therapeutics | 2.55B |
| IDEAYA Biosciences | 2.54B |
| Enliven Therapeutics | 2.49B |